According to the recent study the interventional cardiology and peripheral vascular device market is projected to reach an estimated $38 billion by 2030 from $26 billion in 2023 at a CAGR of 5.8% from 2023 to 2030. Growth in this market is primarily driven by growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.
A more than 150–page
report is developed to understand trends, opportunities and forecast in
interventional cardiology and peripheral vascular device market by type
(interventional cardiology and peripheral vascular device), device (angioplasty
balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC
filter, embolic protection device, guidewires, arteriotomy closure device,
intravascular ultrasound system, and synthetic surgical graft), end user
(hospitals and ambulatory surgical centers), and region (North America, Europe,
Asia Pacific, and the Rest of the World).
“Interventional cardiology market is expected to remain the
largest segment during the forecast period.”
Based on type, the
interventional cardiology and peripheral vascular device market is segmented
into interventional cardiology and peripheral vascular device. Lucintel
forecasts that the interventional cardiology market is expected to remain the
largest segment because of new technology innovations and aging population.
“Within the interventional cardiology and peripheral vascular
device market, the hospitals segment is expected to remain the largest end use.”
Based on end use the
hospitals segment is expected to witness the highest growth over the forecast
period due to the growing public-private partnerships to improve access to healthcare
services along with rapid developments in healthcare infrastructure and
improving access to healthcare services. These are the major driving factors
for growth in this segment over the forecast period.
“Asia pacific will dominate the interventional cardiology and
peripheral vascular device market in near future.”
Asia Pacific is expected
to be the largest region with the highest growth over the forecast period due
to the presence of a large pool of respiratory patients, increasing healthcare
expenditure, rapidly developing healthcare infrastructure, rising per capita
income, growing middle-class population, and growing prevalence of tobacco
smoking in this region.
Major players of
interventional cardiology and peripheral vascular device market are adopting
various growth strategies like new product launches, expansions, merger and
acquisitions, partnerships, agreements, and collaborations to expand their
presence in this market. Abbott Laboratories, Boston Scientific Corporation,
Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R.
Bard, Inc., Cook Medical Inc., Terumo Corporation, Cardinal Health Inc are
among the major interventional cardiology and peripheral vascular device
providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Explore Our Latest Publications
Helicobacter
Pylori Testing Market
Healthcare Big Data Analytic
Market
Liver Health Supplement Market
No comments:
Post a Comment